Early control of C‐reactive protein levels with non‐biologics is associated with slow radiographic progression in radiographic axial spondyloarthritis. (21st December 2021)
- Record Type:
- Journal Article
- Title:
- Early control of C‐reactive protein levels with non‐biologics is associated with slow radiographic progression in radiographic axial spondyloarthritis. (21st December 2021)
- Main Title:
- Early control of C‐reactive protein levels with non‐biologics is associated with slow radiographic progression in radiographic axial spondyloarthritis
- Authors:
- Koo, Bon San
Lee, Seunghun
Oh, Ji Seon
Park, Seo Young
Ahn, Ga Young
Shin, Ji Hui
Joo, Kyung Bin
Kim, Tae‐Hwan - Abstract:
- Abstract: Aim: Predicting radiographic progression is vital for assessing the prognosis of patients with radiographic axial spondyloarthritis, and C‐reactive protein (CRP) may be a valuable biomarker for this purpose. This study aimed to investigate the relationship between changes in the CRP level and spinal radiographic progression in patients with radiographic axial spondyloarthritis who were initially treated with non‐biologics. Methods: Patients with radiographic axial spondyloarthritis who were followed up for 18 years at a single center and initially treated with nonsteroidal anti‐inflammatory drugs and/or conventional disease‐modifying antirheumatic drugs for 3 months were included. Patients with a CRP level of <0.8 mg/dL or 50% of the baseline CRP at 3 months were assigned to the controlled CRP group (n = 351), and the remaining patients were assigned to the uncontrolled CRP group (n = 452). A generalized estimating equation was used to analyze the differences in the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) between the 2 groups. Results: The increase in the mSASSS was slower in the controlled CRP group than in the uncontrolled CRP group (interaction term β = −.499, 95% confidence interval −0.699 to −0.300). Conclusion: Controlled CRP achieved in response to initial treatment with non‐biologic agents for 3 months was significantly associated with a slower rate of spinal radiographic change in patients with radiographic axial spondyloarthritis. TheAbstract: Aim: Predicting radiographic progression is vital for assessing the prognosis of patients with radiographic axial spondyloarthritis, and C‐reactive protein (CRP) may be a valuable biomarker for this purpose. This study aimed to investigate the relationship between changes in the CRP level and spinal radiographic progression in patients with radiographic axial spondyloarthritis who were initially treated with non‐biologics. Methods: Patients with radiographic axial spondyloarthritis who were followed up for 18 years at a single center and initially treated with nonsteroidal anti‐inflammatory drugs and/or conventional disease‐modifying antirheumatic drugs for 3 months were included. Patients with a CRP level of <0.8 mg/dL or 50% of the baseline CRP at 3 months were assigned to the controlled CRP group (n = 351), and the remaining patients were assigned to the uncontrolled CRP group (n = 452). A generalized estimating equation was used to analyze the differences in the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) between the 2 groups. Results: The increase in the mSASSS was slower in the controlled CRP group than in the uncontrolled CRP group (interaction term β = −.499, 95% confidence interval −0.699 to −0.300). Conclusion: Controlled CRP achieved in response to initial treatment with non‐biologic agents for 3 months was significantly associated with a slower rate of spinal radiographic change in patients with radiographic axial spondyloarthritis. The CRP level at 3 months after initial non‐biologic treatment is a good predictor of radiographic progression. … (more)
- Is Part Of:
- International journal of rheumatic diseases. Volume 25:Number 3(2022)
- Journal:
- International journal of rheumatic diseases
- Issue:
- Volume 25:Number 3(2022)
- Issue Display:
- Volume 25, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 25
- Issue:
- 3
- Issue Sort Value:
- 2022-0025-0003-0000
- Page Start:
- 311
- Page End:
- 316
- Publication Date:
- 2021-12-21
- Subjects:
- ankylosing spondylitis -- C‐reactive protein -- prognosis -- radiography
Rheumatology -- Periodicals
Rheumatology -- Asia -- Periodicals
Rheumatology -- Pacific Area -- Periodicals
Rheumatic Diseases -- Periodicals
Connective Tissue Diseases -- Periodicals
Immune System Diseases -- Periodicals
616.723 - Journal URLs:
- http://ejournals.ebsco.com/direct.asp?JournalID=715072 ↗
http://www.blackwell-synergy.com/loi/ijrd ↗
http://www.blackwellpublishing.com/aims.asp?ref=1756-1841&site=1 ↗
http://www3.interscience.wiley.com/journal/120118343/grouphome/home.html ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1756-185X ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1756-185X.14268 ↗
- Languages:
- English
- ISSNs:
- 1756-1841
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.538180
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21094.xml